New England Journal of Medicine最新文献

筛选
英文 中文
The Risks of Pharmaceutical Tariffs for Generic Drug Availability. 药品关税对仿制药可获得性的风险。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-27 DOI: 10.1056/nejmp2508626
Thomas J Hwang,Quoc-Dien Trinh,Kerstin N Vokinger
{"title":"The Risks of Pharmaceutical Tariffs for Generic Drug Availability.","authors":"Thomas J Hwang,Quoc-Dien Trinh,Kerstin N Vokinger","doi":"10.1056/nejmp2508626","DOIUrl":"https://doi.org/10.1056/nejmp2508626","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"18 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates. Reply. 心血管危险因素对寿命估计的全球影响。回复。
IF 78.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 DOI: 10.1056/NEJMc2511206
Christina Magnussen, Thiess Lorenz, Stefan Blankenberg
{"title":"Global Effect of Cardiovascular Risk Factors on Lifetime Estimates. Reply.","authors":"Christina Magnussen, Thiess Lorenz, Stefan Blankenberg","doi":"10.1056/NEJMc2511206","DOIUrl":"https://doi.org/10.1056/NEJMc2511206","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"393 12","pages":"1247-1248"},"PeriodicalIF":78.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145139477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Art within Evidence - Balancing Anticoagulant Duration in VTE Care. 证据范围内的艺术——在静脉血栓栓塞治疗中平衡抗凝时间。
IF 78.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 Epub Date: 2025-08-30 DOI: 10.1056/NEJMe2510701
Neil A Zakai
{"title":"Art within Evidence - Balancing Anticoagulant Duration in VTE Care.","authors":"Neil A Zakai","doi":"10.1056/NEJMe2510701","DOIUrl":"10.1056/NEJMe2510701","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"1229-1230"},"PeriodicalIF":78.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dr. Kolhouse and the Cowboy. 科尔豪斯博士和牛仔。
IF 78.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 Epub Date: 2025-09-20 DOI: 10.1056/NEJMp2501894
Mark Earnest
{"title":"Dr. Kolhouse and the Cowboy.","authors":"Mark Earnest","doi":"10.1056/NEJMp2501894","DOIUrl":"10.1056/NEJMp2501894","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"1151-1153"},"PeriodicalIF":78.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Fizzy Fix. 碳酸饮料。
IF 78.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 DOI: 10.1056/NEJMimc2502450
Matthew A Crane, Nicholas G Economos, Anand Vaidya, Caroline M Apovian, Nicolette J Rodriguez
{"title":"A Fizzy Fix.","authors":"Matthew A Crane, Nicholas G Economos, Anand Vaidya, Caroline M Apovian, Nicolette J Rodriguez","doi":"10.1056/NEJMimc2502450","DOIUrl":"https://doi.org/10.1056/NEJMimc2502450","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"393 12","pages":"e20"},"PeriodicalIF":78.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145139410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonoperative Management of Mismatch Repair-Deficient Tumors. 错配修复缺陷肿瘤的非手术治疗。
IF 78.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 DOI: 10.1056/NEJMc2510154
Christopher D Jakubowski, Amit Verma, Benjamin A Gartrell
{"title":"Nonoperative Management of Mismatch Repair-Deficient Tumors.","authors":"Christopher D Jakubowski, Amit Verma, Benjamin A Gartrell","doi":"10.1056/NEJMc2510154","DOIUrl":"https://doi.org/10.1056/NEJMc2510154","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"393 12","pages":"1241-1242"},"PeriodicalIF":78.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145139515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates. 心血管危险因素对寿命估计的全球影响。
IF 78.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 DOI: 10.1056/NEJMc2511206
Samaneh Akbarpour, Yosra Azizpour, Bagher Larijani
{"title":"Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.","authors":"Samaneh Akbarpour, Yosra Azizpour, Bagher Larijani","doi":"10.1056/NEJMc2511206","DOIUrl":"https://doi.org/10.1056/NEJMc2511206","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"393 12","pages":"1246"},"PeriodicalIF":78.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145139439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebral Embolic Protection during TAVI. TAVI期间的脑栓塞保护。
IF 78.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 DOI: 10.1056/NEJMc2510558
Samir R Kapadia
{"title":"Cerebral Embolic Protection during TAVI.","authors":"Samir R Kapadia","doi":"10.1056/NEJMc2510558","DOIUrl":"https://doi.org/10.1056/NEJMc2510558","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"393 12","pages":"1243"},"PeriodicalIF":78.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145139499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy. 耐西古兰Ziclumeran基因编辑在遗传性ATTR伴多发性神经病中的应用。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 DOI: 10.1056/nejmoa2510209
Julian D Gillmore,Ed Gane,Jörg Täubel,Björn Pilebro,Andoni Echaniz-Laguna,Justin Kao,William Litchy,Safi Shahda,Alexandra Haagensen,Liron Walsh,Derek Smith,Jessica Kachadourian,Jonathan H Ward,David Lebwohl,Peijuan Zhu,Yuanxin Xu,Adia Leung,Alison Sonderfan,David E Gutstein,Garen Manvelian,David Adams
{"title":"Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy.","authors":"Julian D Gillmore,Ed Gane,Jörg Täubel,Björn Pilebro,Andoni Echaniz-Laguna,Justin Kao,William Litchy,Safi Shahda,Alexandra Haagensen,Liron Walsh,Derek Smith,Jessica Kachadourian,Jonathan H Ward,David Lebwohl,Peijuan Zhu,Yuanxin Xu,Adia Leung,Alison Sonderfan,David E Gutstein,Garen Manvelian,David Adams","doi":"10.1056/nejmoa2510209","DOIUrl":"https://doi.org/10.1056/nejmoa2510209","url":null,"abstract":"BACKGROUNDHereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a rare, multisystem, progressive, debilitating, and fatal disease characterized by tissue deposition of misfolded transthyretin (TTR) in peripheral nerves. Nexiguran ziclumeran (nex-z) is an investigational in vivo therapy based on CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats and associated Cas9 endonuclease) that is designed to reduce serum TTR levels through selective inactivation of TTR in the liver.METHODSIn this phase 1, open-label study, we administered one infusion of nex-z to patients with ATTRv-PN. Primary objectives included assessment of the safety and pharmacodynamics of nex-z. Secondary end points included changes in the familial amyloid polyneuropathy stage, polyneuropathy disability score, serum neurofilament light chain (NfL) level, modified body-mass index (modified BMI, defined as the conventional BMI [weight in kilograms divided by square of height in meters] multiplied by the albumin level in grams per liter), and modified Neuropathy Impairment Score+7 (mNIS+7; range, 0 to 304, with higher scores indicating more impairment).RESULTSA total of 36 patients received nex-z; the mean follow-up was 27 months. The mean percent change from baseline in the serum TTR level was -90% at day 28, which was sustained through month 24 (-92%). Treatment-related adverse events included transient infusion-related reactions (in 21 patients), decreased thyroxine level without hypothyroidism or elevated thyrotropin level (in 8), and headache (in 4). One participant died from cardiac amyloidosis, and one withdrew owing to progressive decline in motor function. Serious adverse events were reported in 11 patients. At month 24, the familial amyloid polyneuropathy stage and polyneuropathy disability score remained stable in 29 and 27 patients, respectively; improved in 2 and 5, respectively; and worsened in 2 and 2, respectively. The mean change in the serum NfL level was -9.0 pg per milliliter, and the change in the modified BMI was 24.7. The mean change from baseline in the mNIS+7 was -8.5.CONCLUSIONSA single administration of nex-z in patients with ATTRv-PN was associated with rapid, deep, and durable reductions in serum TTR levels. The results support further investigation of nex-z to treat ATTRv-PN. (Funded by Intellia Therapeutics and Regeneron Pharmaceuticals; ClinicalTrials.gov number, NCT04601051.).","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"30 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis. CD19 CAR - t细胞治疗耐多药溃疡性结肠炎。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-09-25 DOI: 10.1056/nejmc2508023
Fabian Müller,Raja Atreya,Simon Völkl,Michael Aigner,Sascha Kretschmann,Soraya Kharboutli,Moritz Leppkes,Selina Sitte,Deike Strobel,Arndt Hartmann,Saurabh Mehandru,Jean-Frederic Colombel,Georg Schett,Andreas Mackensen,Markus F Neurath
{"title":"CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis.","authors":"Fabian Müller,Raja Atreya,Simon Völkl,Michael Aigner,Sascha Kretschmann,Soraya Kharboutli,Moritz Leppkes,Selina Sitte,Deike Strobel,Arndt Hartmann,Saurabh Mehandru,Jean-Frederic Colombel,Georg Schett,Andreas Mackensen,Markus F Neurath","doi":"10.1056/nejmc2508023","DOIUrl":"https://doi.org/10.1056/nejmc2508023","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"57 1","pages":"1239-1241"},"PeriodicalIF":158.5,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145134143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信